JP2012510515A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012510515A5 JP2012510515A5 JP2011539569A JP2011539569A JP2012510515A5 JP 2012510515 A5 JP2012510515 A5 JP 2012510515A5 JP 2011539569 A JP2011539569 A JP 2011539569A JP 2011539569 A JP2011539569 A JP 2011539569A JP 2012510515 A5 JP2012510515 A5 JP 2012510515A5
- Authority
- JP
- Japan
- Prior art keywords
- acid
- carbonyl
- oxo
- carboxylic acid
- ethyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11946708P | 2008-12-03 | 2008-12-03 | |
| US61/119,467 | 2008-12-03 | ||
| PCT/US2009/064971 WO2010065310A1 (en) | 2008-12-03 | 2009-11-18 | Inhibitors of diacylglycerol acyltransferase |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2012510515A JP2012510515A (ja) | 2012-05-10 |
| JP2012510515A5 true JP2012510515A5 (enExample) | 2013-01-10 |
Family
ID=42231833
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011539569A Withdrawn JP2012510515A (ja) | 2008-12-03 | 2009-11-18 | ジアシルグリセロールアシルトランスフェラーゼの阻害剤 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US8124766B2 (enExample) |
| EP (1) | EP2367817A4 (enExample) |
| JP (1) | JP2012510515A (enExample) |
| CN (1) | CN102239165A (enExample) |
| AU (1) | AU2009322774A1 (enExample) |
| CA (1) | CA2744152A1 (enExample) |
| IL (1) | IL212916A0 (enExample) |
| WO (1) | WO2010065310A1 (enExample) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8153644B2 (en) * | 2007-05-22 | 2012-04-10 | Madrigal Pharmaceuticals, Inc. | Diacylglycerol acyltransferase inhibitors |
| US8115011B2 (en) * | 2007-05-22 | 2012-02-14 | Madrigal Pharmaceuticals, Inc. | Diacylglycerol acyltransferase inhibitors |
| US8211884B2 (en) | 2008-08-06 | 2012-07-03 | Madrigal Pharmaceuticals, Inc. | Diacylglycerol acyltransferase inhibitors |
| JP4900361B2 (ja) * | 2008-10-21 | 2012-03-21 | ソニー株式会社 | 画像処理装置、画像処理方法およびプログラム |
| US8324385B2 (en) * | 2008-10-30 | 2012-12-04 | Madrigal Pharmaceuticals, Inc. | Diacylglycerol acyltransferase inhibitors |
| US8211914B2 (en) * | 2008-12-17 | 2012-07-03 | Madrigal Pharmaceuticals, Inc. | Inhibitors of diacylglycerol acyltransferase |
| PA8854101A1 (es) | 2008-12-18 | 2010-07-27 | Ortho Mcneil Janssen Pharm | Derivados de imidazol bicíclicos sustituidos como moduladores de gamma secretasa |
| WO2010089292A1 (en) | 2009-02-06 | 2010-08-12 | Ortho-Mcneil-Janssen Pharmaceuticals, Inc | Novel substituted bicyclic heterocyclic compounds as gamma secretase modulators |
| TWI461425B (zh) | 2009-02-19 | 2014-11-21 | Janssen Pharmaceuticals Inc | 作為伽瑪分泌酶調節劑之新穎經取代的苯并唑、苯并咪唑、唑并吡啶及咪唑并吡啶衍生物類 |
| EP2427453B1 (en) | 2009-05-07 | 2013-07-17 | Janssen Pharmaceuticals, Inc. | Substituted indazole and aza-indazole derivatives as gamma secretase modulators |
| EA021047B1 (ru) | 2009-07-15 | 2015-03-31 | Янссен Фармасьютикалз, Инк. | Замещенные производные триазола и имидазола в качестве модуляторов гамма-секретазы |
| WO2011031628A1 (en) | 2009-09-14 | 2011-03-17 | Schering Corporation | Inhibitors of diacylglycerol acyltransferase |
| PE20121511A1 (es) | 2010-01-15 | 2012-12-06 | Janssen Pharmaceuticals Inc | Novedosos derivados biciclicos de triazol sustituidos como moduladores de gamma secretasa |
| CA2827969A1 (en) | 2011-03-24 | 2012-09-27 | Janssen Pharmaceuticals, Inc. | Novel substituted triazolyl piperazine and triazolyl piperidine derivatives as gamma secretase modulators |
| EA023045B1 (ru) | 2011-07-15 | 2016-04-29 | Янссен Фармасьютикалз, Инк. | Новые замещенные производные индола в качестве модуляторов гамма-секретазы |
| JP6106745B2 (ja) | 2012-05-16 | 2017-04-05 | ヤンセン ファーマシューティカルズ，インコーポレーテッド | （特に）アルツハイマー病の治療に有用な置換３，４−ジヒドロ−２Ｈ−ピリド［１，２−ａ］ピラジン−１，６−ジオン誘導体 |
| US10112943B2 (en) | 2012-12-20 | 2018-10-30 | Janssen Pharmaceutica Nv | Substituted imidazoles as gamma secretase modulators |
| WO2014111457A1 (en) | 2013-01-17 | 2014-07-24 | Janssen Pharmaceutica Nv | Novel substituted pyrido-piperazinone derivatives as gamma secretase modulators |
| US10562897B2 (en) | 2014-01-16 | 2020-02-18 | Janssen Pharmaceutica Nv | Substituted 3,4-dihydro-2H-pyrido[1,2-a]pyrazine-1,6-diones as gamma secretase modulators |
| IL298592A (en) | 2020-06-24 | 2023-01-01 | Pmv Pharmaceuticals Inc | Combination therapy for treatment of cancer |
| CR20230160A (es) * | 2020-10-08 | 2023-06-02 | Merck Sharp & Dohme Llc | Preparación de derivados de oxindol como nuevos inhibidores de la diacilglicerol o-aciltransferasa 2 |
| WO2024199387A1 (zh) * | 2023-03-30 | 2024-10-03 | 微境生物医药科技(上海)有限公司 | 作为DGKζ抑制剂的化合物 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3250771A (en) * | 1962-12-17 | 1966-05-10 | Geigy Chem Corp | 5-monocarbocyclic aryl-n-lower alkyl-2-pyrrolidine carboxylic acid, esters, amides and derivatives thereof |
| DE2337461A1 (de) * | 1973-07-24 | 1975-02-06 | Boehringer Mannheim Gmbh | Neue indolderivate und verfahren zu deren herstellung |
| US4066654A (en) * | 1975-04-16 | 1978-01-03 | G. D. Searle & Co. | 1-triarylalkyl-4-phenyl-4-piperidine carboxylic acids and derivatives |
| US6495558B1 (en) * | 1999-01-22 | 2002-12-17 | Amgen Inc. | Kinase inhibitors |
| US6756374B2 (en) * | 2001-01-22 | 2004-06-29 | Hoffmann-La Roche Inc. | Diaminothiazoles having antiproliferative activity |
| JP4436129B2 (ja) | 2001-08-31 | 2010-03-24 | サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | ジアリールシクロアルキル誘導体、その製造法及びｐｐａｒ−活性剤としてのその使用 |
| WO2004022551A1 (ja) | 2002-09-06 | 2004-03-18 | Takeda Pharmaceutical Company Limited | フランまたはチオフェン誘導体およびその医薬用途 |
| AU2003293006A1 (en) * | 2002-11-22 | 2004-06-18 | Japan Tobacco Inc. | Fused bicyclic nitrogen-containing heterocycles |
| EP1893592A1 (en) | 2005-06-11 | 2008-03-05 | AstraZeneca AB | Oxadiazole derivatives as dgat inhibitors |
| EP1963313B1 (en) * | 2005-11-28 | 2012-11-14 | Madrigal Pharmaceuticals, Inc. | Inhibitors of diacylglycerol acyltransferase (dgat) |
| US20100093733A1 (en) * | 2007-02-15 | 2010-04-15 | Prosidion Limited | Amide and urea derivatives for the treatment of metabolic diseases |
| CA2686951C (en) | 2007-05-22 | 2016-03-22 | Via Pharmaceuticals, Inc. | Diacylglycerol acyltransferase inhibitors |
-
2009
- 2009-11-18 EP EP09830855A patent/EP2367817A4/en not_active Withdrawn
- 2009-11-18 US US12/621,109 patent/US8124766B2/en not_active Expired - Fee Related
- 2009-11-18 AU AU2009322774A patent/AU2009322774A1/en not_active Abandoned
- 2009-11-18 CN CN2009801482136A patent/CN102239165A/zh active Pending
- 2009-11-18 JP JP2011539569A patent/JP2012510515A/ja not_active Withdrawn
- 2009-11-18 WO PCT/US2009/064971 patent/WO2010065310A1/en not_active Ceased
- 2009-11-18 CA CA2744152A patent/CA2744152A1/en not_active Abandoned
-
2011
- 2011-05-16 IL IL212916A patent/IL212916A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012510515A5 (enExample) | ||
| RU2458920C2 (ru) | Новые соединения | |
| JP2010533722A5 (enExample) | ||
| RU2412192C2 (ru) | Сульфонамидтиазолпиридиновые производные как активаторы глюкокиназы, пригодные для лечения диабета типа 2 | |
| JP2014511869A5 (enExample) | ||
| ME02648B (me) | Jedinjenje pirazin karboksamida | |
| NZ601656A (en) | Pyridyloxyindoles inhibitors of VEGF-R2 and use thereof for treatment of disease | |
| JP2016512825A5 (enExample) | ||
| JP2008517945A5 (enExample) | ||
| RU2010110640A (ru) | Соединения и композиции 5-(4-(галогеналкокси)фенил)пиримидин-2-амина в качестве ингибиторов киназ | |
| HRP20151435T1 (hr) | Diamino heterociklički karboksamidni spoj | |
| HRP20160450T1 (hr) | Novi inhibitori reduktaze s-nitrozoglutationa | |
| HRP20151405T1 (hr) | Novi supstituirani kinolinski spojevi kao inhibitori reduktaze s-nitrosoglutationa | |
| HRP20120048T1 (hr) | Spojevi za i postupci moduliranja fxr | |
| JP2010526129A5 (enExample) | ||
| HRP20140503T1 (hr) | Derivati tieno-piridina kao inhibitori mek | |
| HRP20110058T1 (hr) | 1-[2-(2,4-dimetilfenilsulfanil)fenil]piperazin kao spoj sa kombiniranom aktivnošću vezanom za ponovno preuzimanje serotonina i i 5-ht3 i 5ht1a aktivnošću, za liječenje bolova ili rezidualnih simptoma u depresiji vezanih za san i kogniciju | |
| DOP2017000057A (es) | Forma de dosificacion farmaceutica para administracion oral de un inhibidor de la familia bcl-2 | |
| RU2009119290A (ru) | Производные гидантоина, используемые в качестве ингибиторов ммр | |
| AR082458A1 (es) | Combinacion que comprende un farmaco antipsicotico y un agonista de taar1 | |
| EA200971086A1 (ru) | Фармацевтические композиции и способ лечения шизофрении | |
| ME02465B (me) | Jedinjenje gvanidina | |
| NZ708508A (en) | Methods of treatment using selective bcl-2 inhibitors | |
| NZ593413A (en) | Combinations comprising methotrexate and dhodh inhibitors | |
| RU2010138577A (ru) | ИНГИБИТОРЫ РЕЦЕПТОРА ХЕМОКИНА CxCR3 |